HOLDEN LOWELL THOMAS (CFO) purchased 0.2% of their position (20K shares) of NASCENT BIOTECH INC. on the open market
Open‑market purchase worth $2.8K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/2/2023ACC: 0001477932-23-000693
DirectorOfficer· CFO
+20K
Net shares
Net buyer
$2.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$0.14
Trade value
$2.80K
% of position
0.2%
—
8.40M→8.42M
Total
Net shares
+20K
Net value
$2.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +20K | $0.14 | $2.80K | 0.2% | 8.40M | 8.42M |
| Total | +20K | $2.80K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2M
Total
2M indirect2M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2M | Indirect |
| Total | 2M | 2M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported